Ruxolitinib cream 1.5% twice daily for the treatment of extensive atopic dermatitis in children aged 2-11 years: 52 week results from a maximum-use trial

被引：0

作者：

Bissonnette, Robert ^{[1
]}

Lee, Mark S. ^{[2
]}

Forman, Seth B. ^{[3
]}

Gold, Linda Stein ^{[4
]}

Kallender, Howard ^{[5
]}

Angel, Brett ^{[5
]}

Kuo, Yutzu ^{[5
]}

Paller, Amy S. ^{[6
]}

机构：

[1] Innovaderm Res, Montreal, PQ, Canada

[2] Progress Clin Res, San Antonio, TX USA

[3] ForCare Clin Res, Tampa, FL USA

[4] Henry Ford Hlth Syst, Detroit, MI USA

[5] Incyte Corp, Wilmington, DE USA

[6] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA

来源：

关键词：

atopic dermatitis; pediatric; ruxolitinib cream;

D O I：

10.1093/bjd/ljae266.003

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

603

引用

页数：1